| PRECLINICAL | evidence | Genome-wide screening for prognosis-predicting genes in early-stage non-small-cell lung cancer. | Thymosin beta 4 | — | 2004-08-01 |
| PRECLINICAL | evidence | Thymosin beta 4 and its N-terminal tetrapeptide, AcSDKP, inhibit proliferation, and induce dysplastic, non-apoptotic nuclei and degranulation of mast cells. | Tbeta4 | — | 2004-07-01 |
| PRECLINICAL | evidence | Coupling of folding and binding of thymosin beta4 upon interaction with monomeric actin monitored by nuclear magnetic resonance. | Thymosin beta 4 | — | 2004-05-28 |
| PRECLINICAL | evidence | Cloning of cDNA encoding a regeneration-associated muscle protease whose expression is attenuated in cell lines derived from Duchenne muscular dystrophy patients. | Thymosin β4 | Muscle growth & preservation · preclinical | 2004-05-01 |
| PRECLINICAL | evidence | Thymosin-beta4 inhibits corneal epithelial cell apoptosis after ethanol exposure in vitro. | Tbeta4 | Longevity & cellular aging · preclinical | 2004-04-01 |
| PRECLINICAL | evidence | Structure of the integrin binding fragment from fibrillin-1 gives new insights into microfibril organization. | TB4 | — | 2004-04-01 |
| PRECLINICAL | evidence | [Bioinformatics analysis to the differentially expressed genes of normal mucosa and carcinoma of colon]. | Thymosin beta 4 | Gut barrier & GI healing · preclinical | 2004-03-01 |
| PRECLINICAL | evidence | Thymosin beta 4 induces the synthesis of plasminogen activator inhibitor 1 in cultured endothelial cells and increases its extracellular expression. | Thymosin beta 4 | preclinical | 2004-02-15 |
| PRECLINICAL | evidence | Mechanism of actin polymerization in cellular ATP depletion. | Thymosin beta 4 | — | 2004-02-13 |
| PRECLINICAL | evidence | Thymosin beta 4 stimulates laminin-5 production independent of TGF-beta. | Tbeta4 | Eye & vision health | 2004-02-01 |
| PRECLINICAL | evidence | Thymosin beta4 increases hair growth by activation of hair follicle stem cells. | Thymosin beta 4 | — | 2004-02-01 |
| PRECLINICAL | evidence | Fusion between phagosomes, early and late endosomes: a role for actin in fusion between late, but not early endocytic organelles. | Thymosin beta 4 | — | 2004-01-01 |
| PRECLINICAL | evidence | Thymosin beta4: a new molecular target for antitumor strategies. | Thymosin beta 4 | — | 2003-11-19 |
| PRECLINICAL | evidence | Role of thymosin beta4 in tumor metastasis and angiogenesis. | Thymosin beta 4 | — | 2003-11-19 |
| PRECLINICAL | evidence | High sequence coverage of proteins isolated from liquid separations of breast cancer cells using capillary electrophoresis-time-of-flight MS and MALDI-TOF MS mapping. | Thymosin beta 4 | preclinical | 2003-11-15 |
| PRECLINICAL | evidence | The actin binding site on thymosin beta4 promotes angiogenesis. | Thymosin beta 4 | — | 2003-11-01 |
| PRECLINICAL | evidence | Structural plasticity of functional actin: pictures of actin binding protein and polymer interfaces. | Thymosin beta 4 | — | 2003-10-01 |
| PRECLINICAL | evidence | From the first to the second domain of gelsolin: a common path on the surface of actin? | Thymosin β4 | — | 2003-09-25 |
| PRECLINICAL | evidence | MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. | Thymosin beta 4 | — | 2003-09-11 |
| PRECLINICAL | evidence | Thymosin beta(4) reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock. | Tbeta4 | — | 2003-08-01 |
| PRECLINICAL | evidence | Reduction of thymosin beta4 and actin in HL60 cells during apoptosis is preceded by a decrease of their mRNAs. | Tbeta4 | — | 2003-08-01 |
| PRECLINICAL | evidence | Downregulation of Cap43 gene by von Hippel-Lindau tumor suppressor protein in human renal cancer cells. | Thymosin β4 | preclinical | 2003-07-20 |
| PRECLINICAL | evidence | Use of ProteinChip array surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) to identify thymosin beta-4, a differentially secreted protein from lymphoblastoid cell lines. | Thymosin beta 4 | Immune function · preclinical | 2003-07-01 |
| PRECLINICAL | evidence | Comparative evaluation of four trityl-type amidomethyl polystyrene resins in Fmoc solid phase peptide synthesis. | Thymosin beta 4 | — | 2003-07-01 |
| PRECLINICAL | evidence | [Identification of differentially expressed genes of acute hypoxia-treated HepG2 cells and hypoxia-acclimatized HepG2 cells]. | Thymosin beta 4 | — | 2003-06-25 |
| PRECLINICAL | evidence | Overexpression of the thymosin beta-4 gene is associated with malignant progression of SW480 colon cancer cells. | Tbeta4 | — | 2003-05-22 |
| PRECLINICAL | evidence | A phage display-based method for determination of relative affinities of mutants. Application of the actin-binding motifs in thymosin beta 4 and the villin headpiece. | Thymosin beta 4 | — | 2003-05-09 |
| PRECLINICAL | evidence | Anti-inflammatory effects in the skin of thymosin-beta4 splice-variants. | Tbeta4 | — | 2003-05-01 |
| PRECLINICAL | evidence | Actin binding proteins: regulation of cytoskeletal microfilaments. | Thymosin β4 | — | 2003-04-01 |
| PRECLINICAL | evidence | Thymosin beta 4 interactions. | Thymosin beta 4 | — | 2003-01-01 |
| PRECLINICAL | evidence | Expression of hematopoietic inhibitory factors in mouse fibroblasts, macrophages and endothelial cells. | Tbeta4 | — | 2003-01-01 |
| PRECLINICAL | evidence | The profile of gene expression of human marrow mesenchymal stem cells. | Thymosin beta 4 | — | 2003-01-01 |
| PRECLINICAL | evidence | The thymosins. Prothymosin alpha, parathymosin, and beta-thymosins: structure and function. | Thymosin beta 4 | Wound healing | 2003-01-01 |
| PRECLINICAL | evidence | Antimicrobial peptides from human platelets. | Tbeta4 | — | 2002-12-01 |
| PRECLINICAL | evidence | The effect of thymosin beta4 on articular cartilage chondrocyte matrix metalloproteinase expression. | Thymosin beta 4 | Bone & joint health · preclinical | 2002-11-01 |
| PRECLINICAL | evidence | Thymosin beta4 regulation, expression and function in aortic valve interstitial cells. | Thymosin beta 4 | — | 2002-09-01 |
| PRECLINICAL | evidence | Discovery of over-expressed genes and genetic alterations in breast cancer cells using a combination of suppression subtractive hybridization, multiplex FISH and comparative genomic hybridization. | Thymosin beta 4 | — | 2002-09-01 |
| PRECLINICAL | evidence | Isolation of differentially expressed genes in NPM-ALK-positive anaplastic large cell lymphoma. | Thymosin β4 | — | 2002-09-01 |
| PRECLINICAL | evidence | Hepatocyte growth factor upregulates thymosin beta4 in human umbilical vein endothelial cells. | Thymosin beta 4 | preclinical | 2002-08-16 |
| PRECLINICAL | evidence | Cloning expression in E.coli and biological activity of human thymosin beta(4). | Thymosin beta 4 | Immune function | 2002-07-01 |
| PRECLINICAL | evidence | Contribution of Ena/VASP proteins to intracellular motility of listeria requires phosphorylation and proline-rich core but not F-actin binding or multimerization. | Thymosin beta 4 | Skin appearance & aging | 2002-07-01 |
| PRECLINICAL | evidence | Chemotherapeutic drugs change actin skeleton organization and the expression of beta-thymosins in human breast cancer cells. | Tbeta4 | — | 2002-05-01 |
| PRECLINICAL | evidence | Thymosin beta4 is released from human blood platelets and attached by factor XIIIa (transglutaminase) to fibrin and collagen. | Thymosin beta 4 | Skin appearance & aging | 2002-05-01 |
| PRECLINICAL | evidence | The beta-thymosins, small actin-binding peptides widely expressed in the developing and adult cerebellum. | Tbeta4 | — | 2002-04-01 |
| PRECLINICAL | evidence | Thymosin beta4 promotes human conjunctival epithelial cell migration. | Tbeta4 | preclinical | 2002-04-01 |
| PRECLINICAL | evidence | Polymerisation of chemically cross-linked actin:thymosin beta(4) complex to filamentous actin: alteration in helical parameters and visualisation of thymosin beta(4) binding on F-actin. | Thymosin beta 4 | Muscle growth & preservation · preclinical | 2002-01-25 |
| PRECLINICAL | evidence | Interaction of SV40 large T antigen with components of the nucleo/cytoskeleton. | Thymosin β4 | — | 2001-12-01 |
| PRECLINICAL | evidence | Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord. | Thymosin beta 4 | — | 2001-12-01 |
| PRECLINICAL | evidence | Interaction of ADP-ribosylated actin with actin binding proteins. | Thymosin beta 4 | Muscle growth & preservation | 2001-11-09 |
| PRECLINICAL | evidence | Structural biology. Actin' up. | Thymosin beta 4 | — | 2001-07-27 |